Previous 10 | Next 10 |
Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...
Penumbra, Inc . (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the Indigo ® Aspiration System. As part of the Indigo Aspiration System, the Indigo Aspiration Cathete...
ALAMEDA, Calif. , Dec. 31, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14 , 2020. A webcast of the pres...
The only real problem I had with Penumbra ( PEN ) when I last wrote about the stock in June was the take-no-prisoners valuation. The company has continued to post good growth since then, with quarterly revenue growth rates around 25%, but expectations were so high already that the shares r...
Penumbra ( PEN +0.4% ) appoints Maggie Yuen as CFO of of the company, effective December 2, 2019. More news on: Penumbra, Inc., Healthcare stocks news, Read more ...
ALAMEDA, Calif. , Nov. 25, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the appointment of Maggie Yuen as CFO of Penumbra, effective December 2 , 2019. Ms. Yuen is a seasoned execu...
ALAMEDA, Calif. , Nov. 19, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host an Investor Day on Tuesday, December 3, 2019 in Boston, MA at 8:30am Eastern Time . Webcast & Conference Call Information A webcast of the event can be accesse...
Penumbra, Inc. (PEN) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Sri Kosaraju – President and Chief Financial Officer Conferen...
Image source: The Motley Fool. Penumbra Inc (NYSE: PEN) Q3 2019 Earnings Call Nov 7, 2019 , 4:30 p.m. ET Operator Continue reading
Penumbra (NYSE: PEN ): Q3 GAAP EPS of $0.32 beats by $0.16 . More news on: Penumbra, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...